How do CD4+CD25+ regulatory T cells control autoimmunity?

被引:201
作者
Bluestone, JA
Tang, QZ
机构
[1] Univ Calif San Francisco, Ctr Diabet, Dept Med, San Francisco, CA 94143 USA
[2] Univ Calif San Francisco, Ctr Diabet, Dept Pathol, San Francisco, CA 94143 USA
关键词
D O I
10.1016/j.coi.2005.09.002
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Any scientist opening up an immunology journal today will observe immediately that suppressor T cells, renamed,regulatory T cells' (Tregs) have become a central concept in the immunology lexicon. Hundreds of Treg publications over the past few years have validated the existence of this unique T cell lineage armed with an ability to regulate autoimmunity. The CD4(+)CD25(+)Foxp3(+) Treg subset develops in the thymus, can be induced in the periphery during the course of normal immune responses and utilizes a T cell repertoire skewed towards autoantigens. Despite these advances, however, there is,still controversy over their mechanism of action. This confusion stems from the differences observed in in vitro versus in vivo studies. Recent in vivo analyses support a model in which Tregs directly or indirectly alter the activation and differentiation of pathogenic T cells through an effect on antigen presenting cells.
引用
收藏
页码:638 / 642
页数:5
相关论文
共 50 条
  • [21] Role of LAG-3 in regulatory T cells
    Huang, CT
    Workman, CJ
    Flies, D
    Pan, XY
    Marson, AL
    Zhou, G
    Hipkiss, EL
    Ravi, S
    Kowalski, J
    Levitsky, HI
    Powell, JD
    Pardoll, DM
    Drake, CG
    Vignali, DAA
    [J]. IMMUNITY, 2004, 21 (04) : 503 - 513
  • [22] Developmental stage, phenotype, and migration distinguish naive- and effector/memory-like CD4+ regulatory T cells
    Huehn, J
    Siegmund, K
    Lehmann, JCU
    Siewert, C
    Haubold, U
    Feuerer, M
    Debes, GF
    Lauber, J
    Frey, O
    Przybylski, GK
    Niesner, U
    de la Rosa, M
    Schmidt, CA
    Bäuer, R
    Buer, J
    Scheffold, A
    Hamann, A
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 2004, 199 (03) : 303 - 313
  • [23] Infectious tolerance:: Human CD25+ regulatory T cells convey suppressor activity to conventional CD4+ T helper cells
    Jonuleit, H
    Schmitt, E
    Kakirman, H
    Stassen, M
    Knop, J
    Enk, AH
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 2002, 196 (02) : 255 - 260
  • [24] Treatment with granulocyte colony-stimulating factor prevents diabetes in NOD mice by recruiting plasmacytoid dendritic cells and functional CD4+CD25+ regulatory T-cells
    Kared, H
    Masson, A
    Adle-Biassette, H
    Bach, JF
    Chatenoud, L
    Zavala, F
    [J]. DIABETES, 2005, 54 (01) : 78 - 84
  • [25] CD4+ CD25+ regulatory T cell repertoire formation in response to varying expression of a neo-self-antigen
    Lerman, MA
    Larkin, J
    Cozzo, C
    Jordan, MS
    Caton, AJ
    [J]. JOURNAL OF IMMUNOLOGY, 2004, 173 (01) : 236 - 244
  • [26] Levings AK, 2005, CURR TOP MICROBIOL, V293, P303
  • [27] Defective suppressor function in CD4+CD25+ T-cells from patients with type 1 diabetes
    Lindley, S
    Dayan, CM
    Bishop, A
    Roep, BO
    Peakman, M
    Tree, TIM
    [J]. DIABETES, 2005, 54 (01) : 92 - 99
  • [28] Dendritic cells induce autoimmune diabetes and maintain disease via de novo formation of local lymphoid tissue
    Ludewig, B
    Odermatt, B
    Landmann, S
    Hengartner, H
    Zinkernagel, RM
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1998, 188 (08) : 1493 - 1501
  • [29] T-cell priming by dendritic cells in lymph nodes occurs in three distinct phases
    Mempel, TR
    Henrickson, SE
    von Andrian, UH
    [J]. NATURE, 2004, 427 (6970) : 154 - 159
  • [30] Two-photon imaging of lymphocyte motility and antigen response in intact lymph node
    Miller, MJ
    Wei, SH
    Parker, I
    Cahalan, MD
    [J]. SCIENCE, 2002, 296 (5574) : 1869 - 1873